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The inflammatory response of sepsis results in organ dysfunction, including myocardial dysfunction. Myocardial
dysfunction is particularly important in patients with severe septic shock who progress to a hypodynamic pre-terminal
phase. Multiple aspects of this septic inflammatory response contribute to the pathogenesis of decreased ventricular
contractility. Inflammatory cytokines released by inflammatory cells contribute as does nitric oxide released by vascular
endothelium and by cardiomyocytes. Endotoxins and other pathogen molecules induce an intramyocardial inflammatory
response by binding Toll-like receptors on cardiomyocytes that then signal via NF-κB. These processes alter cardiomyocyte
depolarization and, therefore, contractility. The particular role of the cardiomyocyte sodium current has not been
characterized. Now new information suggests that the septic inflammatory response impairs normal depolarization by
altering the cardiomyocyte sodium current. This results in decreased ventricular contractility. This is important because
new targets for therapeutic intervention can be considered and new approaches to evaluation of this problem can be
contemplated.In the previous issue of Critical Care, Koesters and
colleagues [1] contribute to our understanding of sepsis-
induced ventricular dysfunction. Sepsis-induced ventricular
dysfunction is increasingly recognized as a contributor to
cardiovascular dysfunction during septic shock [2]. Vaso-
dilation induced by nitric oxide (NO) and other mediators
figures prominently in the hypotensive distributive shock
circulation induced by sepsis. But additional sepsis-induced
ventricular dysfunction can result in an inadequate cardiac
output response to decreased afterload, resulting in pre-
terminal hypodynamic septic shock [3]. It could be argued
that decreased ventricular contractility during sepsis is not
a major issue in hyperdynamic septic shock characterized
by an elevated cardiac output. Yet death due to septic shock
is characterized by onset and progression of a hypodynamic
phase that, in the volume-resuscitated patient, can only be
explained by myocardial dysfunction. So ventricular dys-
function may be less important in septic shock survivors
but myocardial dysfunction of sepsis may well be the decid-
ing factor in early mortality of septic shock.Correspondence: Keith.Walley@hli.ubc.ca
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2014The septic inflammatory response involves a surprising
number of intersecting pathways, many of which contribute
to ventricular dysfunction. Pathogen-associated molecular
patterns (PAMPs) released by infecting organisms bind in-
nate immune receptors on inflammatory cells (for example,
monocytes, neutrophils) but also bind innate immune
receptors in the heart [4] and within the coronary macro-
and micro-circulation. For example, cardiomyocytes ex-
press a variety of Toll-like receptors that, when bound by a
PAMP, induce intracellular signaling via NF-κB, which then
induces an intra-myocardial inflammatory response [5]. In
addition, early pro-inflammatory cytokines, such as tumor
necrosis factor-α and interleukin-1β [6], released by simi-
larly activated inflammatory cells contribute in part by in-
creased production of NO [7]. NO can decrease ventricular
contractility by activating guanylate cyclase, which results
in decreased intracellular calcium concentration. A variety
of inflammatory mediators induce expression of cellular
adhesion molecules by endothelial cells of the coronary
microcirculation and even by cardiomyocytes. Ligation of
cardiomyocyte-expressed intracellular adhesion molecule
(ICAM)-1 by ligands such as fibrinogen result in decreased
contractility [8]. Chemotactic cytokines such as macro-
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kines leads to retention of neutrophils and other leukocytes
in the coronary circulation and extravasation of these
inflammatory cells into the myocardium. Contact between
leukocytes and cardiomyocytes mediated by ICAM-1 and
other adhesion molecules also results in a decrease in
cardiomyocyte contractility [9]. Ligation of cardiomyocyte-
expressed ICAM-1 signals via the cortical actin cytoskel-
eton resulting in altered intracellular calcium flux [10].
Alteration of intracellular calcium flux is a fundamental
later step in the mechanistic pathway to decreased cardio-
myocyte and ventricular contractility. In the previous issue
of Critical Care Koesters, Engisch and Rich investigate the
role of cardiomyocyte sodium current [1]. Alterations in
sodium current have been observed in skeletal muscle and
in nerves so these authors tested the hypothesis that similar
abnormalities may be observed in myocardial tissue.
Papillary muscles excised from septic rats 1 day after cecal
ligation and puncture were studied. They found that action
potentials of papillary muscles from septic rats differed
substantially from those of controls. Action potential mag-
nitude was decreased, the threshold was increased, and the
rate of rise was decreased. Notably, the threshold and rate
of rise of the action potential are known to be heavily
influenced by the sodium channel. To put these results
into context, these investigators compared these intra-
abdominal sepsis observations to those where the sodium
channel was inhibited using tetrodotoxin. There were simi-
larities between sepsis-induced changes and tetrodotoxin-
induced changes. Both intra-abdominal sepsis and a
comparable concentration of tetrodotoxin (similar effects
on the action potential) decreased papillary muscle force by
more than half. The authors conclude that the sepsis-
induced changes in sodium channel function could contrib-
ute substantially to decreased ventricular contractility
during sepsis.
To determine whether other channel currents could have
contributed, additional characteristics of the septic action
potential were measured. There was no significant change
in resting potential, a property influenced by non-voltage
gated K channels. Membrane resistance and action poten-
tial duration decreased only slightly in septic action poten-
tials, suggesting a limited role, at best, for voltage gated K
and Ca channels. Inhibition of the L-type Ca current
reduced contractility, as expected.
Thus, these novel results raise the possibility that
sepsis-induced decreases in sodium channel flux may
contribute to ventricular dysfunction during sepsis. This
conjecture is based on similarity between sepsis-induced
and tetrodotoxin-induced changes and therefore is not
mechanistic proof of a role of the sodium channel.
Nevertheless, moving the focus of investigation towards
intracellular signaling expands our knowledge of poten-
tial mechanistic pathways contributing to myocardialdysfunction of sepsis. This is important because new
targets for therapeutic intervention can be considered
and new approaches to evaluation of this problem can
be contemplated, possibly even based on surface mea-
surements of electrical properties of the heart.
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